Gastroprotective agent compliance in patients at risk suffering from a Gastrointestinal(GI) ulcer

Study identifier:NIS-PFR-DUM-2010/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

Gastroprotective agent compliance in patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer with non-steroidal anti-inflammatory drug (NSAID) in France

Medical condition

Gastrointestinal Hemorrhage

Phase

Healthy volunteers

Yes

Study drug

Sex

All

Actual Enrollment

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Oct 2010

Estimated Primary Completion Date: 01 Apr 2011

Estimated Study Completion Date: 01 Apr 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Oct 2010 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
1	-

"There is no result for the study"

Documents available

Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca France MC Clinical Study Information

+ 33 1 41 29 40 25

florence.thomas@astrazeneca.com

Investigators

Principal Investigator

Jean-Francois Bretagne

Service gastro-enterologie et hepatologieCHRU Pontchaillou35033 RENNES cedex France